Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Amwell (NYSE: AMWL), a digital healthcare leader, announced it will report its fourth quarter operating results for the period ending December 31, 2022, on February 22, 2023, at 5:00 p.m. Eastern Time. Following the earnings release, the management team will host a live conference call and webcast to discuss results and provide business updates. Access to the webcast will be available on the company's investor relations website. Amwell connects healthcare providers, insurers, and patients, serving over 80 million lives through its digital care platform.
Amwell® (NYSE: AMWL) announced its third-quarter financial results for 2022, reporting a total revenue of $69.2 million, an 11% increase from $62.2 million in Q3 2021. Subscription revenue grew by 19% to $31.9 million, while AMG Visit revenue was $28.8 million. Gross margin stood at 40%. The net loss was ($70.6 million), slightly higher than the ($69.7 million) loss in Q2 2022. Active providers increased by 23% to 98,500. The company expects to meet its annual revenue guidance of $275 to $285 million and has refined its Adjusted EBITDA outlook to between ($180) million and ($190) million.
Amwell (NYSE: AMWL) announced the appointment of Robert Webb to its Board of Directors, effective immediately. With over 30 years of experience in healthcare technology, Mr. Webb aims to enhance Amwell's market position and growth trajectory. His previous roles include CEO of Optum's consumer network and President of UnitedHealth Group Ventures. Amwell focuses on digital healthcare enablement, connecting various stakeholders to improve care accessibility and quality. The company supports over 2,000 hospitals and 55 health plan partners, impacting over 80 million lives.
BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital healthcare leader, announced key participation in upcoming investor conferences. On November 10, 2022, CEO Dr. Ido Schoenberg and CFO Bob Shepardson will attend the Credit Suisse Healthcare Conference, hosting a fireside chat at 8:30 a.m. PT. Shepardson will also engage in meetings at the Needham & Co. Virtual Health Tech One-on-One Conference on November 15 and at BTIG's Virtual Healthcare Day on November 21. They will meet investors again on November 30 at the Piper Sandler Healthcare Conference in New York City.
Amwell (NYSE: AMWL) will report third-quarter operating results for the period ending September 30, 2022, on November 7, 2022. Following the earnings release, management will host a live conference call at 5:00 PM ET to discuss the results and provide a business update. Investors can access the webcast on the company's website or by calling U.S. and international numbers. Amwell is a leading digital healthcare platform, enabling improved access to affordable care, serving over 2,000 hospitals and covering more than 80 million lives.
Amwell (NYSE: AMWL) announces key executive appointments, bringing a combined 40 years of experience to its leadership team. Vaughn Paunovich joins as Executive Vice President of Enterprise Platforms, focusing on technological delivery and innovation for the Converge platform. Matthew McAllister takes on the role of Chief Product Officer, overseeing product management and design. CEO Roy Schoenberg emphasized the importance of these roles amidst the digital transformation in healthcare, positioning Amwell as a partner in meeting customer needs for integrated technological solutions.
Amwell (NYSE: AMWL) has launched its inaugural Environmental, Social and Governance (ESG) Framework, emphasizing its commitment to sustainable growth. The Framework focuses on three pillars: People, promoting talent development and wellbeing; Products, enhancing digital care delivery through its Converge™ platform; and Operations, ensuring high ethical standards and robust data privacy. CEO Dr. Ido Schoenberg stated this marks a significant milestone in Amwell's ESG journey, with plans for transparency and progress updates in the future.
BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital care delivery leader, will have management participate in upcoming investor conferences. On September 8, 2022, Dr. Ido Schoenberg and CFO Bob Shepardson will engage in a fireside chat at the Wells Fargo Healthcare Conference at 11 a.m. ET. Subsequently, on September 13, 2022, they will attend the Morgan Stanley 20th Annual Global Healthcare Conference in New York City at 1:30 PM ET. Webcasts will be available at investors.amwell.com.
On August 8, 2022, Amwell (NYSE: AMWL) received the 2022 North America Customer Value Leadership Award from Frost & Sullivan for its Converge platform. This recognition highlights Amwell’s commitment to improving digital healthcare delivery through comprehensive technology solutions for healthcare organizations. The Converge platform aims to enhance operational efficiency, improve patient-provider interactions, and address staffing shortages. The integration of AI through partnerships, including with Google Cloud, further elevates its service offerings, ensuring flexible and effective digital care.
Amwell (NYSE: AMWL) reported its Q2 2022 financial results, achieving $64.5 million in total revenue, a 7% increase from Q2 2021. Subscription revenue rose 10% to $29.6 million, while AMG visit revenue grew 8% to $29.7 million. Gross margin was reported at 43.4%, and adjusted EBITDA improved to ($42.8) million. Active providers surged 46% to 103,500, with total visits increasing 19% to 1.5 million. Amwell expects 2022 revenue between $275 and $285 million.